Abstract
An important goal of personalized medicine is to identify heterogeneity in treatment effects and then use that heterogeneity to target the intervention to those most likely to benefit. Heterogeneity is assessed using the predicted individual treatment effects framework, and a permutation test is proposed to establish if significant heterogeneity is present given the covariates and predictive model or algorithm used for predicted individual treatment effects. We first show evidence for heterogeneity in the effects of treatment across an illustrative example data set. We then use simulations with two different predictive methods (linear regression model and Random Forests) to show that the permutation test has adequate type-I error control. Next, we use an example dataset as the basis for simulations to demonstrate the ability of the permutation test to find heterogeneity in treatment effects for a predicted individual treatment effects estimate as a function of both effect size and sample size. We find that the proposed test has good power for detecting heterogeneity in treatment effects when the heterogeneity was due primarily to a single predictor, or when it was spread across the predictors. Power was found to be greater for predictions from a linear model than from random forests. This non-parametric permutation test can be used to test for significant differences across individuals in predicted individual treatment effects obtained with a given set of covariates using any predictive method with no additional assumptions.
| Original language | English |
|---|---|
| Pages (from-to) | 2369-2381 |
| Number of pages | 13 |
| Journal | Statistical Methods in Medical Research |
| Volume | 30 |
| Issue number | 11 |
| Early online date | 27 Sept 2021 |
| DOIs | |
| Publication status | Published - Nov 2021 |
Bibliographical note
Funding Information:The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This paper was partially supported by grant # MR/L010658/1 awarded to Thomas Jaki by the United Kingdom Medical Research Council and by grant # 1R01HD054736 awarded to M. Lee Van Horn by the National Institute of Child Health and Human Development.
Publisher Copyright:
© The Author(s) 2021.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This paper was partially supported by grant # MR/L010658/1 awarded to Thomas Jaki by the United Kingdom Medical Research Council and by grant # 1R01HD054736 awarded to M. Lee Van Horn by the National Institute of Child Health and Human Development.
Keywords
- heterogeneity in treatment effects
- permutation test
- personalized medicine
- Predicted individual treatment effects
- Random Forests